What are the clinical outcomes of patients with atrial fibrillation receiving dual antiplatelet therapy compared to those receiving an addition of an anticoagulant after coronary stent implantation?
A systematic review and meta-analysis of observational studies by Chaudhary et al. (2016) found that patients with atrial fibrillation receiving dual antiplatelet therapy had a lower risk of major adverse cardiovascular events compared to those receiving an addition of an anticoagulant after coronary stent implantation.